Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Phase II Trial of Silymarin for Patients With Chronic Hepatitis C Who Have Failed Conventional Antiviral Treatment (SyNCH)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00680342
Recruitment Status : Completed
First Posted : May 20, 2008
Last Update Posted : March 18, 2013
Sponsor:
Collaborators:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
University of Pennsylvania
University of North Carolina, Chapel Hill
Thomas Jefferson University
Beth Israel Deaconess Medical Center
University of Pittsburgh
Information provided by (Responsible Party):
National Center for Complementary and Integrative Health (NCCIH)